Please use this identifier to cite or link to this item:
Title: Cell immune response in mice skin stimulated with different adjuvants by intradermal route.
Authors: Mathias, Fernando Augusto Siqueira
Cardoso, Jamille Mirelle de Oliveira
Reis, Levi Eduardo Soares
Souza, Juliana Vitoriano de
Moreira, Nádia das Dores
Ostolin, Thais Lopes Valentim Di Paschoale
Brito, Rory Cristiane Fortes de
Soares, Rodrigo Dian de Oliveira Aguiar
Vieira, Paula Melo de Abreu
Carneiro, Cláudia Martins
Roatt, Bruno Mendes
Reis, Alexandre Barbosa
Keywords: Aluminum hydroxide
Glucopyranosyl Lipid A Stable Emulsion
Immune response
Inflammatory cell infiltrates
Issue Date: 2022
Citation: MATHIAS, F. A. S. et al. Cell immune response in mice skin stimulated with different adjuvants by intradermal route. Journal of Vaccines, Immunology and Immunopathology, v. 1, p. 170-2022, 2022. Disponível em: <>. Acesso em: 11 out. 2022.
Abstract: Adjuvants act in the innate immunity and, when combined to vaccine antigens, can produce a more intense response, improving the antigen presentation, directing the immune system, excellent for new vaccine formulations. This study evaluated the use of the intradermal route and the immune response triggered by a single dose of the adjuvants Aluminum Hydroxide (Al(OH)3 ), Montanide Pet Gel A (MPGA), Glucopyranosyl Lipid A Stable Emulsion (GLA-SE), and Resiquimod (R-848) in the mice skin. As control mice received sterile saline. MPGA and GLA-SE led to cell recruitment when compared with control group, with intense presence of neutrophils in first 12 hours, replaced by macrophages after 168 hours. R-848 and Al(OH)3 showed similar cell recruitment profiles. Regarding cytokine production, groups that received MPGA and GLA-SE produced high levels of IL-6, TNF-α, and IFN-γ. R-848 and Al(OH)3 groups displayed similar profile of cytokine production only at the first hour. Our results suggest that the intradermal route is efficient inducing immune system activation and GLA-SE was promising adjuvants for a type 1 immune response vaccine.
ISSN: 2575-789X
Appears in Collections:DEACL - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
  Restricted Access
785,97 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.